An Intervention Program to Control Diabetes

Abbott

Status and phase: Completed; Phase 4

Conditions: Diabetes Mellitus, Type 2

Treatments: Other: daily enteral nutritional product and/or behavioral changes

Study type: Interventional

Funder types: Industry

Identifiers

NCT00543621

Welltech Study

Details and patient eligibility

About

Study to evaluate the effectiveness of a structured intervention to improve diabetes control.

Enrollment: 150 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• informed consent
• 18-70 adults
• Type 2 Diabetes
• Males and non-pregnant females

Exclusion criteria

• Use of exogenous insulin for glucose control
• Use of medications or supplements for weight loss
• Advanced diabetes complications
• Recent history of cardiovascular event

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)